Bank of New York Mellon’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-352
| Closed | -$6K | – | 4639 |
|
|
2022
Q3 | $6K | Hold |
352
| – | – | ﹤0.01% | 4534 |
|
|
2022
Q2 | $18K | Sell |
352
-1,469
| -81% | -$109K | ﹤0.01% | 4507 |
|
|
2022
Q1 | $257K | Hold |
1,821
| – | – | ﹤0.01% | 4104 |
|
|
2021
Q4 | $311K | Buy |
1,821
+46
| +3% | +$17.2K | ﹤0.01% | 4080 |
|
|
2021
Q3 | $884K | Buy |
1,775
+165
| +10% | +$76.5K | ﹤0.01% | 3461 |
|
|
2021
Q2 | $807K | Buy |
1,610
+1,258
| +357% | +$676K | ﹤0.01% | 3544 |
|
|
2021
Q1 | $179K | Sell |
352
-37
| -10% | -$19.1K | ﹤0.01% | 4085 |
|
|
2020
Q4 | $185K | Buy |
389
+215
| +124% | +$70.5K | ﹤0.01% | 3994 |
|
|
2020
Q3 | $50K | Buy |
+174
| New | +$43.1K | ﹤0.01% | 4026 |
|
|
2019
Q4 | – | Sell |
-140
| Closed | -$21K | – | 4256 |
|
|
2019
Q3 | $21K | Hold |
140
| – | – | ﹤0.01% | 4181 |
|
|
2019
Q2 | $16K | Sell |
140
-552
| -80% | -$87.4K | ﹤0.01% | 4196 |
|
|
2019
Q1 | $117K | Sell |
692
-4
| -0.6% | -$685 | ﹤0.01% | 3977 |
|
|
2018
Q4 | $83K | Hold |
696
| – | – | ﹤0.01% | 3991 |
|
|
2018
Q3 | $106K | Buy |
696
+21
| +3% | +$8.78K | ﹤0.01% | 4033 |
|
|
2018
Q2 | $446K | Buy |
675
+502
| +290% | +$376K | ﹤0.01% | 3678 |
|
|
2018
Q1 | $176K | Buy |
173
+47
| +37% | +$39.3K | ﹤0.01% | 3959 |
|
|
2017
Q4 | $154K | Sell |
126
-11
| -8% | -$5.17K | ﹤0.01% | 4001 |
|
|
2017
Q3 | $25K | Buy |
137
+11
| +9% | +$1.74K | ﹤0.01% | 4197 |
|
|
2017
Q2 | $20K | Sell |
126
-324
| -72% | -$65.5K | ﹤0.01% | 4232 |
|
|
2017
Q1 | $109K | Sell |
450
-1
| -0.2% | -$269 | ﹤0.01% | 4011 |
|
|
2016
Q4 | $122K | Sell |
451
-12
| -3% | -$2.86K | ﹤0.01% | 3990 |
|
|
2016
Q3 | $103K | Sell |
463
-24
| -5% | -$6.73K | ﹤0.01% | 4035 |
|
|
2016
Q2 | $189K | Buy |
487
+274
| +129% | +$299K | ﹤0.01% | 3915 |
|
|
2016
Q1 | $143K | Buy |
213
+49
| +30% | +$33K | ﹤0.01% | 3885 |
|
|
2015
Q4 | $172K | Buy |
164
+7
| +4% | +$6.93K | ﹤0.01% | 3912 |
|
|
2015
Q3 | $136K | Sell |
157
-3
| -2% | -$2.51K | ﹤0.01% | 4023 |
|
|
2015
Q2 | $114K | Sell |
160
-765
| -83% | -$815K | ﹤0.01% | 4019 |
|
|
2015
Q1 | $2.09M | Buy |
925
+250
| +37% | +$426K | ﹤0.01% | 2838 |
|
|
2014
Q4 | $695K | Hold |
675
| – | – | ﹤0.01% | 3484 |
|
|
2014
Q3 | $715K | Sell |
675
-12
| -2% | -$20.2K | ﹤0.01% | 3485 |
|
|
2014
Q2 | $1.72M | Buy |
687
+125
| +22% | +$255K | ﹤0.01% | 2991 |
|
|
2014
Q1 | $1.07M | Buy |
562
+57
| +11% | +$135K | ﹤0.01% | 3236 |
|
|
2013
Q4 | $1.08M | Buy |
505
+154
| +44% | +$364K | ﹤0.01% | 3264 |
|
|
2013
Q3 | $789K | Buy |
351
+12
| +4% | +$23.2K | ﹤0.01% | 3363 |
|
|
2013
Q2 | $586K | Buy |
+339
| New | +$538K | ﹤0.01% | 3433 |
|
Other funds holding AMPE
CFO
CC
WWM
BJL
HF
ARG
CCMW
Bank of New York Mellon's AMPE Position: Q4 2022 in Review
Bank of New York Mellon sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q4 2022, closing a stake of 352 shares — an estimated $6K sold.
Bank of New York Mellon first reported a position in AMPE in Q2 2013 and held it in 35 quarters. The position peaked at $2.09M in Q1 2015. 32 funds tracked by Wall St. Rank hold AMPE as of Q4 2022.
- Bank of New York Mellon reported no remaining Ampio Pharmaceuticals Inc. position as of Q4 2022 after selling out during the quarter.
- Bank of New York Mellon sold 352 Ampio Pharmaceuticals Inc. shares in Q4 2022, an estimated $6K.
- Bank of New York Mellon first reported a position in Ampio Pharmaceuticals Inc. in Q2 2013 and held it in 35 quarters.
- Bank of New York Mellon's Ampio Pharmaceuticals Inc. position peaked at $2.09M in Q1 2015.
- 32 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q4 2022.
Based on Bank of New York Mellon's 13F filing for Q4 2022, filed 14 Feb 2023.